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1. Introduction  
Most cancers results from man-made and natural environmental exposures (such as tobacco 
smoke; chemical pollutants in air, water, food, drugs; radon; and infectious agents) acting in 
concert with both genetic and acquired characteristics. It has been estimated that without 
these environmental factors, cancer incidence would be dramatically reduced, by as much as 
80%-90% (Perera, 1996). The modulation of environmental factors by host susceptibility was 
rarely evaluated. However, within the past few years, the interaction between 
environmental factors and host susceptibility factors has become a very active area of 
research (Perera, 2000). Molecular biology as a tool for use in epidemiological studies has 
significant potential in strengthening the identification of cancers associated with 
environmental exposures related to lifestyle, occupation, or ambient pollution. In molecular 
epidemiology, laboratory methods are employed to document the molecular basis and 
preclinical effects of environmental carcinogenesis (Portier & Bell, 1998). 
Molecular epidemiology has become a major field of research and considerable progress has 
been made in validation and application of biomarkers and its greatest contribution has 
been the insights provided into interindividual variation in human cancer risk and the 
complex interactions between environmental factors and host susceptibility factors, both 
inherited and acquired, in the multistage process of carcinogenesis (Perera, 2000). 
The possibility to use a biomarker to substitute classical endpoints, such as disease incidence 
or mortality is the most promising feature and one that is most likely to affect public health. 
The use of events that are on the direct pathways from the initiation to the occurrence of 
disease to surrogate the disease incidence is a very appealing approach, which is currently 
investigated in different fields (Bonassi & Au, 2002). 
Biological monitoring of workers has three main aims: the primary is individual or collective 
exposure assessment, the second is health protection and the ultimate objective is 
occupational health risk assessment. It consists of standardized protocols aiming to the 
periodic detection of early, preferably reversible, biological signs which are indicative, if 
compared with adequate reference values, of an actual or potential condition of exposure, 
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effect or susceptibility possibly resulting in health damage or disease. These signs are 
referred to as biomarkers (Manno et al., 2010). 
There has been dramatic progress in the application of biomarkers to human studies of 
cancer causation. Progress has been made in the development and validation of biomarkers 
that are directly relevant to the carcinogenic process and that can be used in large-scale 
epidemiologic studies (Manno et al., 2010). 
There are many important aspects to consider when a biomonitoring study is designed. For 
instance, there is needed a detail information on genotoxin exposure, e.g. type of toxin, 
duration of exposure, commencing date of exposure relative to sampling date of buccal cells, 
in order to achieve a meaningful interpretation of data. It will also helps to identify key 
variables affecting the observed frequency of biomarkers, like age, gender, vitamin B status, 
genotype and smoking status (Thomas et al., 2009). 
Based on the impact on genotoxicity biomarkers in peripheral blood lymphocytes on the 
design of biomonitoring studies, Battershill et al. (2008) study have considered a 
strong/sufficient correlation between micronucleus (MN) frequency and increasing age. The 
effect is more pronounced in females than in males, with the increase more marked after 30 
years of age. There are studies that also demonstrated a strong correlation between age and 
MN frequency and suggested that chromosome loss is a determining factor in this increase. 
In what concern to gender, is also documented a gender difference in the background 
incidence of MN in peripheral blood lymphocytes (PBL), with the frequency being 
consistently higher in females. A study that assessed MN, chromosomal aberrations and 
sister chromatid exchange showed highly significant elevations in MN in lymphocytes of 
women (29% when adjusted for age and smoking) whereas chromosomal aberrations and 
sister chromatid exchange remained unchanged. This may reflect aneuploidy detected in 
MN assays (Battershill et al., 2008). 
In respect to smoking, although the link between smoking and cancer is strong and 
exposure to genotoxic carcinogens present in tobacco smoke has been convincingly 
demonstrated, interestingly the same convincing association is less apparent when assessing 
biomonitoring studies of genotoxicity. HUMN project study about tobacco smoke, the 
majority of the laboratories showed no significant differences between smokers and non-
smokers and the pooled analysis, interestingly, indicated an overall decrease for all smokers 
compared to controls (Battershill et al., 2008). 
It was verified a weak/insufficient evidence for association with genotoxicity end points 
and alcohol consumption. Alcohol consumption has been causally associated with cancer at 
a number of sites (e.g. head and neck cancer). Alcoholic beverages have not been reported to 
induce mutagenic effects in rodents. The evidence regarding an effect of drinking alcoholic 
beverages on increased MN or substitute for chromosomal aberrations formation in PBL is 
inconclusive (Battershill et al., 2008). 
2. Biomarkers – General definitions  
Biomarkers have been defined by the National Academy of Sciences (USA) as an alteration 
in cellular or biochemical components, processes, structure or functions that is measurable 
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in a biological system or sample. The traditional, generally accepted classification of 
biomarkers into three main categories - biomarkers of exposure, effect, and susceptibility; 
depending on their toxicological significance (Manno et al., 2010). 
A biomarker can potentially be any substance, structure or process that could be monitored 
in tissues or fluids and that predicts or influences health, or assesses the incidence or 
biological behaviour of a disease. Identification of biomarkers that are on causal pathway, 
have a high probability of reflecting health or the progression to clinical disease, and have 
the ability to account for all or most of the variation in a physiological state or the 
preponderance of cases of the specified clinical outcome, have largely remained elusive 
(Davis et al., 2007). 
A biomarker of exposure is a chemical or its metabolite or the product of an interaction 
between a chemical and some target molecule or macromolecule that is measured in a 
compartment or a fluid of an organism (Manno et al., 2010). 
A biomarker of effect is a measurable biochemical, structural, functional, behavioural or any 
other kind of alteration in an organism that, according to its magnitude, can be associated 
with an established or potential health impairment or disease. A sub-class of biomarkers of 
effect is represented by biomarkers of early disease (Manno et al., 2010). 
A biomarker of susceptibility may be defined as an indicator of an inherent or acquired 
ability of an organism to respond to the challenge of exposure to a chemical (Manno et al., 
2010). 
Although the different types of biomarkers are considered for classification purposes, as 
separate and alternative, in fact it is not always possible to attribute them to a single 
category. The allocation of a biomarker to one type or the other sometimes depends on its 
toxicological significance and the specific context in which the test is being used (Manno et 
al., 2010). 
2.1 Genotoxicity biomarkers 
As a subtype of biomarkers of effect there are biomarkers of genotoxicity, generally used to 
measure specific occupational and environmental exposures or to predict the risk of disease 
or to monitor the effectiveness of exposure control procedures in subjects to genotoxic 
chemicals (Manno et al., 2010). 
Cytogenetic biomarkers are the most frequently used endpoints in human biomonitoring 
studies and are used extensively to assess the impact of environmental, occupational and 
medical factors on genomic stability (Barrett et al., 1997; Battershill et al., 2008) and 
lymphocytes are used as a surrogate for the actual target tissues of genotoxic carcinogens 
(Barrett et al., 1997). The evaluation of MN in PBL is the most commonly used technique, 
although cells such as buccal epithelium are also utilized (Battershill et al., 2008). 
MN assay is one of the most sensitive markers for detecting DNA damage, and has been 
used to investigate genotoxicity of a variety of chemicals. MN testing with interphase cells is 
more suited as a cytogenetic marker because it is not limited to metaphases, and has the 
advantage of allowing rapid screening of a larger numbers of cells than in studies with sister 
chromatid exchanges or chromosomic aberrations (Ishikawa et al., 2003). 
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MN analysis, therefore, appears to be a good tool for investigating the effects of clastogens 
and aneuploidogens in occupational and environmental exposure in human epidemiological 
studies (Ishikawa et al., 2003) and are described as a promising approach with regard to 
assessing health risks (Battershill et al., 2008). 
2.1.1 Cytokinesis-Block micronucleus assay 
The scope and the application of cytokinesis-block MN assay (CBMN) in biomonitoring has 
also been expanded in recent years so that in addition to scoring MN in binucleate cells, 
there are proposals to evaluate MN in mononucleate cells (to provide a more comprehensive 
assessment of DNA damage), nucleoplasmic bridges (indicative of DNA misrepair, 
chromosome rearrangement or telomere endfusions) and nuclear buds (a measure of gene 
amplification or acentric fragments). Fenech (2007), has proposed that CBMN assay can be 
used to measure chromosomal instability, mitotic dysfunction and cell death (necrosis and 
apoptosis) and has suggested the term CBMN assay. Identification of the contents of MN 
(e.g. presence and absence of centromeres) is now considered important in the evaluation of 
MN in biomonitoring studies, providing insight into mechanisms underpinning the positive 
results reported, i.e. to differentiate between clastogens and aneugenic responses 
(Battershill, et al., 2008). 
The CBMN assay is a comprehensive system for measuring DNA damage; cytostasis and 
cytotoxicity-DNA damage events are scored specifically in once-divided binucleated cells 
and include: micronucleus (MN), nucleoplasmic bridges (NPB) and nuclear buds (NBUDs). 
Cytostatic effects are measured via the proportion of mono-, bi- and multinucleated cells 
and cytotoxicity via necrotic and/or apoptotic cell ratios (Fenech, 2002a, 2006, 2007). 
MN originate from chromosome fragments or whole chromosomes that lag behind 
anaphase during nuclear division. The CBMN assay is the preferred method for measuring 
MN in cultured human and/or mammalian cells because scoring is specifically restricted to 
once-divided binucleated cells, which are the cells that can express MN. In the CBMN assay, 
once-divided cells are recognized by their binucleated appearance after blocking cytokinesis 
with cytochalasin-B (Cyt-B), an inhibitor of microfilament ring assembly required for the 
completion of cytokinesis. 
The CBMN assay allows measuring chromosome breakage, DNA misrepair, chromosome 
loss, non-disjunction, necrosis, apoptosis and cytostasis. Also measure NPB, a biomarker of 
dicentric chromosomes resulting from telomere end-fusions or DNA misrepair, and to 
measure NBUDs, a biomarker of gene amplification. 
Because of its reliability and good reproducibility, the CBMN assay has become one of the 
standard cytogenetic tests for genetic toxicology testing in human and mammalian cells 
(Fenech, 2002b, 2007). 
NPB occur when centromeres of dicentric chromosomes are pulled to opposite poles of the 
cell at anaphase. There are various mechanisms that could lead to NPB formation following 
DNA misrepair of strand breaks in DNA. Typically, a dicentric chromosome and an acentric 
chromosome fragment are formed that result in the formation of an NPB and an MN, 
respectively. Misrepair of DNA strand breaks could also lead to the formation of dicentric 
ring chromosomes and concatenated ring chromosomes which could also result in the 
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formation of NPB. An alternative mechanism for dicentric chromosome and NPB formation 
is telomere end fusion caused by telomere shortening, loss of telomere capping proteins or 
defects in telomere cohesion. The importance of scoring NPB should not be underestimated 
because it provides direct evidence of genome damage resulting for misrepaired DNA 
breaks or telomere end fusions, which is otherwise not possible to deduce by scoring MN 
only (Fenech, 2007 ; Thomas et al., 2003).  
NBUD are biomarkers of elimination of amplified DNA and/or DNA repair complexes. The 
nuclear budding process has been observed in cultures grown under strong selective 
conditions that induce gene amplification as well as under moderate folic acid deficiency. 
Amplified DNA may be eliminated through recombination between homologous regions 
within amplified sequences forming mini-circles of acentric and atelomeric DNA (double 
minutes), which localized to distinct regions within the nucleus, or through the excision of 
amplified sequences after segregation to distinct regions of the nucleus. The process of 
nuclear budding occurs during S phase and the NBUD are characterized by having the same 
morphology as an MN with the exception that they are linked to the nucleus by a narrow or 
wide stalk of nucleoplasmic material depending on the stage of the budding process. The 
duration of the nuclear budding process and the extrusion of the resulting MN from the cell 
remain largely unknown (Fenech, 2007; Serrano-García & Montero-Montoya, 2001; Utani et 
al., 2007).  
Most chemical agents and different types of radiation have multiple effects at the molecular, 
cellular and chromosomal level, which may occur simultaneously and to varying extents 
depending on the dose. Interpretation of genotoxic events in the absence of data on effects in 
nuclear division rate and necrosis or apoptosis can be confounding because observed 
increases in genome damage may be due to indirect factors such as inhibition of apoptosis 
or defective/permissive cell-cycle checkpoints leading to shorter cell-cycle times and higher 
rates of chromosome malsegregation. Furthermore, determining nuclear division index 
(NDI) and proportion of cells undergoing necrosis and apoptosis provides important 
information on cytostatic and cytotoxic properties of the agent being examined that is 
relevant to the toxicity assessment. In human lymphocytes, the NDI also provides a measure 
of mitogen response, which is a useful biomarker of immune response in nutrition studies 
and may also be related to genotoxic exposure. The cytome approach in the CBMN cytome 
assay is important because it allows genotoxic (MN, NPB and NBUD in binucleated cells), 
cytotoxic (proportion of necrotic and apoptotic cells) and cytostatic (proportion and ratios of 
mono-, bi- and multinucleated cells, NDI) events to be captured within one assay (Fenech, 
2005, 2007; Umegaki & Fenech, 2000). 
In conclusion, the CBMN method has evolved into an efficient “cytome” assay of DNA 
damage and misrepair, chromosomal instability, mitotic abnormalities, cell death and 
cytostasis, enabling direct and/or indirect measurement of various aspects of cellular and 
nuclear dysfunction such as: unrepaired chromosome breaks fragments and asymmetrical 
chromosome rearrangement (MN or NPB accompanied by MN originating from acentric 
chromosomal fragments); telomere end fusions (NPB with telomere signals in the middle of 
the bridge and possibly without accompanying MN); malsegregation of chromosomes due 
to spindle or kinetochore defects or cell-cycle checkpoint malfunction (MN containing whole 
chromosomes or asymmetrical distribution of chromosome-specific centromere signals in 
the nuclei of BN cells); nuclear elimination of amplified DNA and/or DNA repair 
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complexes (NBUD); chromosomal instability phenotype and breakage-fusion-bridge cycles 
(simultaneous expression of MN, NPB and NBUD); altered mitotic activity and/or 
cytostasis (NDI) and cell death by necrosis or apoptosis (ratios of necrotic and apoptotic 
cells) (Fenech, 2007). 
2.1.2 Micronucleus in exfoliated buccal cells 
Regeneration is dependent on the number and division rate of the proliferating (basal) cells, 
their genomic stability and their propensity for cell death. These events can be studied in the 
buccal mucosa (BM), which is an easily accessible tissue for sampling cells in a minimally 
invasive manner and does not cause undue stress to study subjects. This method is 
increasingly used in molecular epidemiology studies for investigating the impact of 
nutrition, lifestyle factors, genotoxin exposure and genotype on DNA damage, chromosome 
malsegregation and cell death (Thomas et al., 2009). 
The assay has been successfully to study DNA damage as measured by MN or by the use of 
fluorescent probes to detect in BM is an indication of the regenerative capacity of this tissue. 
The BM provides a barrier to potential carcinogens that can be metabolized to generate 
potential reactive products. As up to 90% of all cancers appear to be epithelial in origin, the 
BM could be used to monitor early genotoxic events as a result of potential carcinogens 
entering the body through ingestion or inhalation. Exfoliated buccal cells have been used 
non-invasively to successfully show the genotoxic effects of lifestyle factors such as tobacco 
smoking, chewing of betel nuts and/or quids, medical treatments, such as radiotherapy as 
well as occupational exposure, exposure to potentially mutagenic and/or carcinogenic 
chemicals, and for studies of chemoprevention of cancer.  
In this assay cells derived from the BM are harvested from the inside of a patient’s mouth 
using a small-headed toothbrush. The cells are washed to remove the debris and bacteria, and 
a single-cell suspension is prepared and applied to a clean slide using a cytocentrifuge. The 
cells are stained with Feulgen and Light Green stain allowing both bright field and permanent 
fluorescent analysis that can be undertaken microscopically (Thomas et al., 2009). 
The Buccal Mucosa Cytome (BMCyt) assay has been used to measure biomarkers of DNA 
damage (MN and/or nuclear buds), cytokinetic defects (binucleated cells) and proliferative 
potential (basal cell frequency) and/or cell death (condensed chromatin, karyorrhexis, 
pyknotic and karyolitic cells). The protocol can also make use of molecular probes for DNA 
adduct, aneuploidy and chromosome break measures within the nuclei of buccal cells. 
Furthermore, chromosome-specific centromeric probes have been used to measure 
aneuploidy by determining the frequency of nuclei with abnormal chromosome number. 
Tandem probes have been successfully applied to measure chromosome breaks in specific 
important regions of the genome (Thomas et al., 2009). 
The methodology and concepts described in this protocol may be applied to other types of 
exfoliated cells such as those of the bladder, nose and cervix but the morphological 
characteristics, sampling and scoring methods are neither properly described nor 
standardized for cells from these tissues (Thomas et al., 2009). 
The time of sampling is also an important variable to consider. As the buccal cells turn over 
every 7-21 days, it is theoretically possible to observe the genotoxic effects of an acute 
exposure approximately 7-21 days later. 
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Ideally, repeat sampling, at least once every 7 days after acute exposure, should be 
performed for 28 days or more so that the kinetics and extent of biomarker induction can be 
thoroughly investigated. In the case of chronic exposure due to habitual diet or alcohol 
consumption or smoking it is recommend that multiple samples are taken at least once 
every 3 months to take into account seasonal variation (Thomas et al., 2009). 
The uniformity of sampling is one of the many aspects to consider; therefore a circular 
expanding motion is used with toothbrush sampling to enhance sampling over a greater 
area and to avoid continual erosion in a single region of the BM. This is performed on the 
inside of both cheeks using a different brush for sampling left and right areas of the mouth 
to maximize cell sampling and to eliminate any unknown biases that may be caused by 
sampling one cheek only. It is important to note that repeated vigorous brushing of the 
same area can lead to increased collection of cells from the less differentiated basal layer. 
About transportation, in some investigations buccal cells may have to be collected from a 
distant site which may cause sample deterioration. About cell fixation, there are many 
possible alternatives of fixatives such as methanol: glacial acetic acid (3:1), 80% methanol or 
ethanol: glacial acetic (3:1). The staining technique recommend is Feulgen because is a DNA-
specific stain and because permanent slides can be obtained that can be viewed under both 
transmitted and/or fluorescent light conditions. There are many false-positive results in MN 
frequency as a result of using Romanowsky-type stains such as Giemsa, May-Grunwald 
Giemsa and/or Leishmann’s which leads to inaccurate assessment of DNA damage. 
Romanowsky stains have been shown to increase the number of false positives as they 
positively stain keratin bodies that are often mistaken for MN and are therefore not 
appropriate for this type of analysis. For these reasons, it is advisable to avoid Romanowsky 
stains in favour of DNA-specific fluorescent-based stains such as propidium iodide, DAPI, 
Feulgen, Hoechst 33258 or Acridine Orange (Thomas et al., 2009). 
The criterion of scoring is originally based in the described by Tolbert et al. that are intended 
for classifying buccal cells into categories that distinguish between “normal” cells and cells 
that are considered “abnormal” on the basis of cytological and nuclear features, which are 
indicative of DNA damage, cytokinetic failure or cell death. Therefore, some definitions of 
the cytological findings are (Thomas et al., 2009): 
Normal “differentiated” cells have a uniformly stained nucleus, which is oval or round in 
shape. They are distinguished from basal cells by their larger size and by their smaller 
nucleus-to-cytoplasm ratio. No other DNA-containing structures apart from the nucleus are 
observed in these cells. These cells are considered to be terminally differentiated relative to 
basal cells, as no mitotic cells are observed in this population. 
Cells with MN are characterized by the presence of both a main nucleus and one more 
smaller nuclear structures called MN. The MN are round or oval in shape and their 
diameter should range between 1/3 and 1/16 of the main nucleus. MN has the same 
staining intensity and texture as the main nucleus. Most cells with MN will ontain only one 
MN but it is possible to find cells with two or more MN. Baseline frequencies for 
micronucleated cells in the BM are usually within the 0.5-2.5 MN/1000 cells range. Cells 
with multiple MN are rare in healthy subjects but become more common in individuals 
exposed to radiation or other genotoxic events. 
Cells with nuclear buds contain nuclei with an apparent sharp constriction at one end of the 
nucleus suggestive of a budding process, i.e. elimination of nuclear material by budding. 
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The NBUD and the nucleus are usually in very close proximity and appear to be attached to 
each other. The NBUD has the same morphology and staining properties as the nucleus; 
however, its diameter may range from a half to a quarter of that of the main nucleus. The 
mechanism leading to NBUD formation is not known but it may be related to the 
elimination of amplified DNA or DNA repair (Thomas et al., 2009). 
The scoring method should include coded slides by a person not involved in the study in 
order to be a blind study. The best magnification to the observation is 1000X. An automated 
procedure of scoring, by image cytometry have to be developed and validated. The authors 
suggested first determine the frequency of all the various cell types in a minimum of 1000 
cells, following this step, the frequency of DNA damage biomarkers (MN and NBUD) is 
scored in a minimum of 2000 differentiated cells (Thomas et al., 2009). 
At the end the results with the BMCyt are dependent on the level of exposure and potency 
of genotoxic or cytotoxic agents, genetic background and the age and gender of the donor 
cells being tested (Thomas et al., 2009). 
Is important to define the role of BMCyt in human biomonitoring as a new tool, less 
invasive in comparison with the CBMN assay, and with many potentialities in molecular 
epidemiology (Thomas et al., 2009). 
Genotoxicity biomonitoring endpoints such as micronucleus, chromosome aberrations and 
8-OHdG and DNA repair measured by comet assay are the most commonly used 
biomarkers in studies evaluating environmental or occupational risks associated with 
exposure to potential genotoxins. A review made by Knudsen and Hansen (2007) about the 
application of biomarkers of intermediate end points in environmental and occupational 
health concluded that MN in lymphocytes provided a promising approach with regard to 
assessing health risks but concluded that the use of chromosome aberrations in future 
studies was likely to be limited by the laborious and sensitive procedure of the test and lack 
of trained cytogeneticists. Methodologies like comet assay in lymphocytes, urine and tissues 
are increasingly being used as markers of oxidative DNA damage (Battershill et al., 2008). 
Studies investigating correlations between endpoints used in genotoxicity biomonitoring 
studies have yielded inconsistent results, where we can find studies that correlate 
cytogenetic and comet and studies there do not achieve a correlation between micronucleus, 
chromosome aberrations and comet. The relative sensitivities of the different endpoints 
discussed, together with the importance of other factors which influence the persistence of 
the biomarkers such as DNA repair, may plausibly impact on background levels in the 
studies considered and would need to be considered before the relationship regarding 
increases in genotoxicity endpoints with exposure to environmental chemicals or 
endogenous factors is explored (Battershill et al., 2008). 
2.2 Application of genotoxicity biomarkers in an occupational setting – 
Histopathology laboratories 
A biomonitoring study was conducted in 7 histopathology laboratories in Portugal in order 
to assess the genotoxicity effects in occupational exposure to formaldehyde (FA). 
FA is a reactive, flammable and colourless gas with a strong and very characteristic pungent 
odour that, when combined with air, can lead to explosive mixtures. FA occurs as an 
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endogenous metabolic product of N-, O- and S-demethylation reactions in most living 
systems. It is used mainly in the production of resins and their applications, such as 
adhesives and binders in wood product, pulp and paper, synthetic vitreous fibre industries, 
production of plastics, coatings, textile finishing and also as an intermediate in the synthesis 
of other industrial chemical compounds. Common non-occupational sources of exposure to 
FA include vehicle emissions, particle boards and similar building materials, carpets, paints 
and varnishes, food and cooking, tobacco smoke and its use as a disinfectant (Conaway et 
al., 1996; Franks, 2005; IARC, 2006; Pala et al., 2008; Viegas & Prista, 2007). 
Commercially, FA is manufactured as an aqueous solution called formalin, usually 
containing 37 to 40% by weight of dissolved FA (Zhang et al., 2009), which is commonly 
used in histopathology laboratories as a cytological fixative to preserve the integrity of 
cellular architecture for diagnosis.  
Exogenous FA can be absorbed following inhalation, dermal or oral exposure, being the 
level of absorption dependent on the route of exposure. The International Agency for 
Research on Cancer (IARC) reclassified FA as a human carcinogen (group 1) in June 2004 
based on “sufficient epidemiological evidence that FA causes nasopharyngeal cancer in humans” 
(IARC, 2006; Zhang et al., 2009). In their review, IARC also concluded that there was ‘‘strong 
but not sufficient evidence for a causal association between leukaemia and occupational exposure to 
FA’’ (Zhang et al., 2009, 2010). However, some studies have also led to mixed results and 
inconclusive evidence (Franks, 2005; Speit et al., 2010).  
The inhalation of vapours can produce irritation to eyes, nose and the upper respiratory 
system. Whilst occupational exposure to high FA concentrations may result in respiratory 
irritation and asthmatic reactions, it may also aggravate a pre-existing asthma condition. 
Skin reactions, following exposure to FA are very common, because the chemical is both 
irritating and allergenic (Pala et al., 2008). FA induces genotoxic and cytotoxic effects in 
bacteria and mammals cells (Ye et al., 2005) and its genotoxicity and carcinogenicity has 
been proved in experimental and epidemiological studies that used proliferating cultured 
mammalian cell lines and human lymphocytes (Pala et al., 2008; Speit et al., 2007) by DNA-
protein cross-links, chromosome aberrations, sister exchange chromatides, and MN (Zhang 
et al., 2009). 
The goal of this study was to compare the frequency of genotoxicity biomarkers, provided 
by CBMN assay in peripheral lymphocytes and MN test in buccal cells between workers of 
histopathology laboratories exposed to FA and individuals non-exposed to FA and other 
environmental factors, namely tobacco and alcohol consumption. 
The study population consisted of 56 workers occupationally exposed to FA from 7 hospital 
histopathology laboratories located in Portugal (Lisbon and Tagus Valley region), and 85 
administrative staff without occupational exposure to FA. The characteristics of both groups 
are described in Table 1.  
Ethical approval for this study was obtained from the institutional Ethical Board and 
Director of the participating hospitals, and all subjects gave informed consent to participate 
in this study. Every person filled a questionnaire aimed at identifying exclusion criteria like 
history of cancer, radio or chemotherapy, use of therapeutic drugs, exposure to diagnostic 
X-rays in the past six months, intake of vitamins or other supplements like folic acid as well 
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as information related to working practices (such as years of employment and the use of 
protective measures). In this study, none of the participants were excluded. 
 Control group Exposed group 
Number of subjects 85 56 
Gender 
Females 
Masculine 
 
54 (64%) 
31 (36%) 
 
37 (66%) 
19 (34%) 
Age 
(mean ±standard deviation,  
in years) 
Range 
 
32.42±8.1 
 
20-53 
 
39.45±11.5 
 
20-61 
Years of employment 
(mean ± sandard deviation,  
in years) 
Range 
 
- 
 
 
14.5 
1-33 
Tobacco consumption 
Non-smokers 
Smokers 
 
60 (70,6%) 
25(29, 4%) 
 
45 (80,4%) 
11 (19,6%) 
Alcohol consumption 
Non-drinkers 
Drinkers 
 
19 (22,4%) 
66 (77,6%) 
 
19 (33,9%) 
37 (66,1%) 
Table 1. Characteristics of the studied sample. 
2.2.1 Environmental monitoring of FA exposure 
Exposure assessment was based on two techniques of air monitoring conducted 
simultaneously.  First, environmental samples were obtained by air sampling with low flow 
pumps for 6 to 8 hours, during a typical working day. FA levels were measured by Gas 
Chromatography analysis and time-weighted average (TWA8h) was estimated according to the 
National Institute of Occupational Safety and Health method NIOSH 2541 (NIOSH, 1994). 
The second method was aimed at measuring ceiling values of FA using Photo Ionization 
Detection (PID) equipment (11.7 eV lamps) with simultaneous video recording. Instantaneous 
values for FA concentration were obtained on a per second basis. This method allows 
establishing a relation between workers activities and FA concentration values, as well to 
reveal the main exposure sources (McGlothlin et al., 2005; Viegas et al., 2010). 
Measurements and sampling were performed in a macroscopic room, provided with fume 
hoods, always near workers breath. 
2.2.2 Biological monitoring 
Evaluation of genotoxic effects was performed by applying the CBMN assay in peripheral 
blood lymphocytes and exfoliated cells from the buccal mucosa. 
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Whole blood and exfoliated cells from the buccal mucosa were collected between 10 a.m. 
and 12 p.m., from every subject and were processed for testing. All samples were coded and 
analyzed under blind conditions. The criteria for scoring the nuclear abnormalities in 
lymphocytes and MN in the buccal cells were the ones described by, respectively, Fenech et 
al. (1999) and Tolbert et al. (1991).  
Heparinized blood samples were obtained by venipuncture from all subjects and freshly 
collected blood was directly used for the micronucleus test. Lymphocytes were isolated 
using Ficoll-Paque gradient and placed in RPMI 1640 culture medium with L-glutamine and 
red phenol added with 10% inactivated fetal calf serum, 50 ug/ml streptomycin + 50U/mL 
penicillin, and 10 ug/mL phytohaemagglutinin. Duplicate cultures from each subject were 
incubated at 37ºC in a humidified 5% CO2 incubator for 44h, and cytochalasin-b 6 ug/mL 
was added to the cultures in order to prevent cytokinesis. After 28h incubation, cells were 
spun onto microscope slides using a cytocentrifuge. Smears were air-dried and double 
stained with May-Grünwald-Giemsa and mounted with Entellan®. One thousand cells were 
scored from each individual by two independent observers in a total of two slides. Each 
observer visualized 500 cells per individual. Cells from the buccal mucosa were sampled by 
endobrushing. Exfoliated cells were smeared onto the slides and fixed with Mercofix®. The 
standard protocol used was Feulgen staining technique without counterstain. Two thousand 
cells were scored from each individual by two independent observers in a total of two 
slides. Each observer visualized 1000 cells per individual. Only cells containing intact nuclei 
that were neither clumped nor overlapped were included in the analysis.  
2.2.3 Statistical analysis 
The deviation of variables from the normal distribution was evaluated by the Shapiro-Wilk 
goodness-of-fit test. The association between each of the genotoxicity biomarkers and 
occupational exposure to FA was evaluated by binary logistic regression. The biomarkers 
were dichotomized (absent/present) and considered the dependent variable in regression 
models where exposure was an independent variable. Odds ratios were computed to 
evaluate the risk of biomarkers presence and their significance was assessed. The non-
parametric Kuskal-Wallis and Mann-Whitney U-tests, were also used to evaluate 
interactions involving confounding factors. All statistical analysis was performed using the 
SPSS package for windows, version 15.0. 
2.2.4 Results 
FA exposure levels 
Results of FA exposure values were determined using the two methods described – the 
NIOSH 2541 method for average concentrations (TWA8h) and the PID method for ceiling 
concentrations. For the first exposure metric, FA mean level of the 56 individuals studied was 
0.16 ppm (0.04 – 0.51 ppm), a value that lies below the OSHA reference value of 0.75 ppm. The 
mean ceiling concentration found in the laboratories was 1.14 ppm (0.18 – 2.93 ppm), a value 
well above the reference of the American Conference of Governmental Industrial Hygienists 
(ACGIH) for ceiling concentrations (0.3 ppm). As for the different tasks developed in 
histopathology laboratories, the highest FA concentration was identified during macroscopic 
specimens’ exam. This task involves a careful observation and grossing of the specimen 
preserved in FA, therefore has direct and prolonged contact with its vapors (Table 2). 
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Tasks Ceiling values (ppm) 
Macroscopic specimen’s exam 2.93 
Disposal of specimen and used solutions 0.95 
Jar filling 2.51 
Specimen wash 2.28 
Biopsy exam 1.91 
Table 2. FA ceiling values (ppm) by tasks in the macroscopy room. 
Genotoxicity biomarkers 
For all genotoxicity biomarkers under study, workers exposed to FA had significantly 
higher mean values than the controls (Table 3). 
In peripheral blood lymphocytes, significant differences (Mann-Whitney test, p<0.001) were 
observed between subjects exposed and non-exposed to FA, namely in mean MN 
(respectively, 3.96±0.525 vs 0.81±0.172), NPB (3.04±0.523 vs 0.18±0.056), and NBUD 
(0.98±0.273 vs 0.07±0.028). In buccal mucosa cells, the MN mean was also significantly 
higher (p=0.002) in exposed subjects (0.96±0.277) than in controls (0.16±0.058).  
 
Mean, MN 
lymphocytes ±S.E. 
(range) 
Mean, NPB±S.E. 
(range) 
Mean, NBUD±S.E.
(range) 
Mean, MN buccal 
cells ±S.E. 
(range) 
Controls 0.81±0.172 (0-7) 0.18±0.056 (0-3) 0.07±0.028 (0-1) 0.16±0.058 (0-2) 
Exposed 3.96±0.525 (0-14) 3.04±0.523 (0-15) 0.98±0.273 (0-13) 0.96±0.277 (0-9) 
p-value <0.001 <0.001 <0.001 0.002 
Table 3. Descriptive statistics of MN in lymphocytes and buccal cells, NPB and NBUD 
means in the studied population (mean ± mean standard error, range and p-value of Mann-
Whitney test) 
Discriminating by occupation, technologists group mean of MN in lymphocytes was 
3.76±0.647; in NBP was 2.62±0.629; in NBUD was 1.09±0.401 and in MN in BM was 
1.18±0.406. In pathologists, the means were 5.00±1.243; 3.75±1.467; 0.33±0.188 and in MN in 
BM was 0.58±0.434, respectively.  
The odds ratios indicate an increased risk for the presence of biomarkers in those exposed to 
FA, compared to non-exposed (Table 4) and they were all significant (p<0.001). 
 OR CI 95% p-value 
MN lymphocytes 9.665 3.81-24.52 <0.001 
NPB 11.97 4.59-31.20 <0.001 
NBUD 9.631 3.12-29.70 <0.001 
MN buccal cells 3.990 1.38-11.58 0.011 
Table 4. Results of binary logistic regression concerning the association between FA and 
genotoxicity biomarkers, as evaluated by the odds ratio (OR). 
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Regarding the impact of the duration of exposure to FA, the mean values of MN in 
lymphocytes and in buccal cells tended to increase with years of exposure (Table 5) but the 
association was not statistically significant. 
Group Years of exposure N 
Mean MN 
lymphocytes 
± S.E. (range)
Mean 
NPB± S.E. 
(range) 
Mean 
NBUD± 
S.E. 
(range)
Mean MN buccal 
cells ± S.E. 
(range) 
Exposed 
> 5 8 2.75±0.940(0-8) 
5.13±1.381
(0-10) 
1.38±0.498
(0-3) 
0.63±0.625 
(0-5) 
6-10 19 3.05±0.775(0-12)
2.42±0.668
(0-9)
1.53±0.731
(0-13)
0.63±0.326 
(0-6) 
11 - 20 12 5.50±1.317(0-14) 
3.33±1.443
(0-14) 
0.33±0.188
(0-2) 
0.83±0.458 
(0-5) 
>21 15 5.00±1.151(0-13) 
2.33±1.036
(0-15) 
0.73±0.248
(0-2) 
1.20±0.8 
(0-9) 
Table 5. Descriptive statistics according to years of exposure to formaldehyde of MN in 
lymphocytes and buccal cells, NPB, and NBUD means in the two groups (mean ± mean 
standard error, range)  
Age and gender are considered the most important demographic variables affecting the MN 
index. However, Table 6 shows that the mean of all the genotoxicity biomarkers did not 
differ between men and women within the exposed and the controls (p> 0.05).  
Groups Gender N 
Mean MN 
lymphocytes ± 
S.E. 
(range)
Mean NPB ± 
S.E. 
(range) 
Mean 
NBUD ± 
S.E. 
(range) 
Mean MN 
buccal 
cells± S.E. 
(range) 
Exposed 
Females 37 4.43±0.676(0-14)
3.03±0.699
(0-15)
1.34±0.418
(0-13)
1.14±0.353 
(0-8) 
Males 19 3.47±0.883(0-13) 
2.95±0.818
(0-14) 
0.42±0.158
(0-2) 
0.74±0.495 
(0-9) 
Controls 
Females 54 0.87±0.229(0-7)
0.22±0.078
(0-3)
0.11±0.043
(0-1)
0.11±0.057 
(0-2) 
Males 31 0.71±0.255(0-6)
0.10±0.071
(0-2) 0.00 
0.26±0.122 
(0-2) 
Table 6. Descriptive statistics by gender of MN in lymphocytes and buccal cells, NPB, and 
NBUD means in the two groups (mean ± mean standard error, range)  
In order to examine the effect of age, exposed and non-exposed individuals were stratified 
by age groups: 20-30, 31-40, and ≥ 41 years old (Table 7). There was no consistent trend 
regarding the variation of biomarkers with age, the only exception being the MN in 
lymphocytes in the exposed group (Kruskal-Wallis, p= 0.006), where the higher means 
where found in the older group. According to Mann-Whitney test, there is a statistical 
significant result between the elder and the older group (20–30 and > 41 years old, p= 0.02), 
however the comparison between 20-30 and 31–40 groups (p= 0.262) and 30–40 and > 41 
groups (p= 0.065) did not reach statistical significance.  
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Groups Age N 
Mean MN 
lymphocytes 
± S.E. 
(range) 
Mean NPB± 
S.E. 
(range) 
Mean 
NBUD± S.E.
(range) 
Mean MN 
buccal cells 
 ± S.E. 
(range) 
 
Exposed 
20-30 18 2.19±0.526 (0-8) 
3.56±0.926 
(0-10) 
1.63±0.816 
(0-13) 
0.75±0.470 
(0-6) 
31-40 11 3.00±0.775 (0-8) 
1.20±0.467 
(0-4) 
0.50±0.224 
(880-2) 
0.40±0.221 
(0-2) 
>41 27 5.54±0.876 (0-15) 
3.00±0.879 
(0-15) 
0.69±0.234 
(0-5) 
1.46±0.503 
(0-9) 
 
Controls 
20-30 36 0.47±0.157
 
(0-3) 
0.14±0.071 
(0-2) 
0.08±0.047 
(0-1) 
0.19±0.96 
(0-2) 
31-40 35 1.14±0.326 (0-7) 
0.20±0.099 
(0-3) 
0.06±0.040 
(0-1) 
0.14±0.83 
(0-2) 
>41 14 0.86±0.501 (0-6) 
0.21±0.155 
(0-2) 
0.07±0.71 
(0-1) 
0.14±0.143 
(0-2) 
Table 7. Age effects on descriptive statistics of MN in lymphocytes and buccal cells, NPB 
and NBUD means in the studied population (mean ± mean standard error, range). 
The interaction between age and gender in determining the frequencies of genotoxicity 
biomarkers was investigated and found to be significant only for MN in lymphocytes in 
exposed subjects (Kruskal-Wallis, p=0.04). In general the MN tended to be more frequent in 
the > 41 years old category in both genders; however women had the higher means. 
Regarding smoking habits, a non-parametric analysis rejected the null hypothesis that 
biomarkers are the same for the four categories (control smokers and non-smokers, exposed 
smokers and non-smokers) (Kruskall-Wallis, p<0.001). However, the analysis of the 
interactions between FA exposure and tobacco smoke between exposed and controls (Mann-
Whitney test) showed that FA exposure, rather than tobacco, has a preponderant effect upon 
the determination of biomarker frequencies. In the control group, non-smokers had slightly 
higher MN means in buccal cells in comparison with smokers; although the result did not 
reach statistical significance (Mann-Whitney, p> 0.05). 
As for alcohol consumption, because uptake reported in enquires may differ considerably 
from real consumption, all consumers were gathered into a single entity, in contrast with 
non-consumers. Nevertheless, no one acknowledged having “heavy drink habits” in the 
questionnaires. 
Overall, biomarkers in controls exhibited higher mean frequencies among alcohol 
consumers than among non-consumers. Among those exposed, however, mean frequencies 
were slightly lower among drinkers, suggesting that exposure was the major predominant 
factor in determining the high biomarker frequencies of those who are exposed. Differences 
between drinkers and non-drinkers were not statistically significant, to the exception of MN 
in lymphocytes in controls (Mann-Whitney, p=0.011), where drinkers have higher means. 
The interaction between alcohol consumption and smoking habits was statistically 
significant (Kruskal-Wallis, p=0.043), as subjects that do not smoke and do not drink tend to 
have lower frequencies of MN in buccal cells than those who drink and smoke, with a 
gradient of frequencies in between.  
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2.2.5 Discussion 
Long exposures to FA, as those to which some workers are subjected for occupational 
reasons, are suspected to be associated with genotoxic effects that can be evaluated by 
biomarkers (Conaway et al., 1996; IARC, 2006; Viegas & Prista, 2007; Zhang et al., 2009). In 
this study the results suggest that workers in histopathology laboratories are exposed to FA 
levels that exceed recommended exposure limits. Macroscopic specimens’ exam, in 
particular, is the task that involves higher exposure, because it requires a greater proximity 
to anatomical species impregnated with FA, as supported by the studies of Goyer et al. 
(2004) and Orsière et al. (2006).  
A statistically significant association was found between FA exposure and biomarkers of 
genotoxicity, namely MN in lymphocytes, NPB, NBUD and MN in buccal cells. 
Chromosome damage and effects upon lymphocytes arise because FA escapes from sites of 
direct contact, such as the mouth, originating nuclear alterations in the lymphocytes of those 
exposed (He & Jin, 1998; IARC, 2006; Orsière et al. 2006; Ye et al., 2005). Our results thus 
corroborate previous reports (Ye et al., 2005) that lymphocytes can be damaged by long term 
FA exposure. Moreover, the changes in peripheral lymphocytes indicate that the cytogenetic 
effects triggered by FA can reach tissues faraway from the site of initial contact (Suruda et 
al., 1993). Long term exposures to high concentrations of FA indeed appear to have a 
potential for DNA damage; these effects were well demonstrated in experimental studies 
with animals, local genotoxic effects following FA exposure, namely DNA-protein cross 
links and chromosome damage (IARC, 2006).  
In humans, FA exposure is associated with an increase in the frequency of MN in buccal 
epithelium cells (Burgaz et al., 2002; Speit et al., 2006, 2007b), as corroborated by the results 
presented here.  
Suruda el al. (1993) claim that although changes in oral and nasal epithelial cells and 
peripheral blood cells do not indicate a direct mechanism leading to carcinogenesis, they 
present evidence that DNA alteration took place. It thus appears reasonable to conclude that 
FA is a cancer risk factor for those who are occupationally exposed in histopathology 
laboratories (IARC, 2006). 
MN and NPB measured in lymphocytes had higher means in pathologists compared with 
technologists. This result can be explained by the exposure to higher concentrations of 
pathologists that perform macroscopic exam. Also this chemical mode of action is more 
related with the concentration than with time of exposure expressed by TWA results.  
In epidemiological studies, it is important to evaluate the role played by common 
confounding factors, such as gender, age, smoking and alcohol consumption, upon the 
association between disease and exposure (Bonassi et al., 2001; Fenech at al., 1999). 
Concerning gender, studies realized by Fenech et al. (1999) and Wojda et al. (2007) reported 
that biomarker frequencies were greater in females than in males by a factor of 1.2 to 1.6 
depending on the age group. With the exception of MN in the buccal cells of controls, the 
results presented here point to females having higher frequencies than males in all 
genotoxicity biomarkers, although the differences usually lacked statistical significance. 
Such trend is concordant with previous studies that reported higher MN frequency in 
lymphocytes in females and a slightly higher MN frequency in buccal cells in males 
(Holland et al., 2008) and that can be explained by preferential aneugenic events involving 
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the X-chromosome. A possible explanation is the micronucleation of the X chromosome, 
which has been shown to occur in lymphocytes in females, both in vitro and in vivo, and that 
can be accounted for by the presence of two X chromosomes. This finding might explain the 
preferential micronucleation of the inactive X (Catalán et al., 1998, 2000a, 2000b).  
Aging in humans appears to be associated with genomic instability. Cytogenetically, ageing 
is associated with a number of gross cellular changes, including altered size and 
morphology, genomic instability and changes in expression and proliferation (Bolognesi et 
al., 1999; Zietkiewicz et al., 2009). It has been shown that a higher MN frequency is directly 
associated with decreased efficiency of DNA repair and increased genome instability 
(Kirsch-Volders et al., 2006; Orsière et al., 2006). The data has shown a significant increase of 
MN in lymphocytes in the exposed group. This can be explained in light of genomic 
instability, understood as an increased amount of mutations and/or chromosomal 
aberrations that cytogenetically translate into a greater frequency of changes in chromosome 
number and/or structure and in the formation of micronuclei (Zietkiewicz et al., 2009). The 
involvement of micronucleation in age-related chromosome loss has been supported by 
several studies showing that the rate of MN formation increases with age, especially in 
women (Catalán et al., 1998). This study provides evidence that age and gender interact to 
determine the frequency of MN in the lymphocytes of exposed subjects. The higher 
incidence of MN in both genders is more manifest in older age groups and the effect of 
gender becomes more pronounced as age increases. Several reports link this observation to 
an elevated loss of X chromosomes (Battershill et al., 2008).  
Tobacco smoke has been epidemiologically associated to a higher risk of cancer 
development, especially in the oral cavity, larynx, and lungs, as these are places of direct 
contact with the carcinogenic tobacco’s compounds. In this study, smoking habits did not 
influence the frequency of the genotoxicity biomarkers; moreover, the frequencies of MN in 
buccal cells were unexpectedly higher in exposed non-smokers than in exposed smokers, 
though the difference was not statistically significant. In most reports, the results about the 
effect of tobacco upon the frequency of MN in human lymphocytes were negative as in 
many instances smokers had lower MN frequencies than non-smokers (Bonassi et al., 2003). 
In the current study, the analysis of the interaction between FA exposure and smoking 
habits indicates that exposure is preponderant in determining the frequency of biomarkers. 
Nevertheless, the effect of smoking upon biomarkers remains controversial. Some studies 
reported an increased frequency of MN in lymphocytes, NPB, and NBUD as a consequence 
of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). 
Still in this study no associations were observed between tobacco and nuclear abnormalities 
(El-Zein et al., 2006, 2008).  
As for alcohol consumption, it did not appear to influence the frequency of genotoxicity 
biomarkers in study, to the exception of MN in lymphocytes in controls (Mann-Whitney, 
p=0.011), with drinkers having higher means. Alcohol is definitely a recognized genotoxic 
agent, being cited as able to potentiate the development of carcinogenic lesions (Ramirez & 
Saldanha, 2002). In our study, drinkers in the control group had higher mean frequencies of 
all biomarkers than non-drinkers, but the differences were only significant for MN in 
lymphocytes. Stich and Rosin (1983) study of alcoholic individuals, reported absence of 
significant differences concerning MN frequencies in buccal cells. That is important to 
corroborate our result, because of the lack of “heavy drinkers” in our study. The same study 
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concluded that neither alcohol nor smoking, alone, increase MN frequency in buccal cells, 
but a combination of both resulted in a significant elevation in micronucleated cells in the 
buccal mucosa. However, the synergism between alcohol consumption and tobacco has not 
been observed to act upon all biomarkers and, in several studies of lifestyle factors, it was 
difficult to differentiate the effect of alcohol from that of smoking (Holland et al., 2008). 
The CBMN assay is a simple, practical, low cost screening technique that can be used for 
clinical prevention and management of workers subjected to occupational carcinogenic 
risks, namely exposure to a genotoxic agent such as FA. The results obtained in this study 
provide unequivocal evidence of association between occupational exposure to 
formaldehyde in histopathology laboratory workers and the presence of nuclear changes.  
Given these results, preventive actions must prioritize safety conditions for those who 
perform macroscopic exams. In general, exposure reduction to FA in this occupational 
setting may be achieved by the use of adequate local exhaust ventilation and by keeping 
biological specimen containers closed during the macroscopic exam. 
3. Conclusion  
Another important application of biological monitoring, besides exposure assessment, is the 
use of biomarkers, at either individual or group level, for the correct interpretation of 
doubtful clinical tests. These are usually performed as part of occupational health 
surveillance program when exposure assessment data are unavailable or are deemed 
unreliable. Health surveillance is the periodical assessment of the workers’ health status by 
clinical, biochemical, imaging or instrumental testing to detect any clinically relevant, 
occupation-dependent change of the single worker’s health. Biomarkers are usually more 
specific and sensitive than most clinical tests and may be more effective, therefore, for 
assessing a causal relationship between health impairment and chemical exposure when a 
change is first detected in exposed workers (Manno et al., 2010). 
Experience in biological monitoring gained in the occupational setting has often been 
applied to assess (the effects of) human exposure to chemicals in the general environment. 
The use of biological fluids/tissues for the assessment of human exposure, effect or 
susceptibility to chemicals in the workplace represents, together with the underlying data 
(e.g. personal exposure and biological monitoring measurements, media-specific residue 
measurements, product use and time-activity information), a critical component of the 
occupational risk assessment process, a rapidly advancing science (Manno et al., 2010). 
Au et al. (1998), advise to put more emphasis on monitoring populations which are known 
to be exposed to hazardous environmental contaminant and on providing reliable health 
risk evaluation. The information can also be used to support regulations on protection of the 
environment. 
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